BORTHWICK KATHLEEN (SVP, Interim CFO) sold 27.6% of their position (2.06K shares) of PASSAGE BIO, INC. on the open market
Open‑market sale worth $38.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/12/2026ACC: 0001987062-26-000001
Officer· SVP, Interim CFO
Since Jul 2023
-2.06K
Net shares
Net seller
$38.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 7.06K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
202.9%
1/8/2026
2.46K→7.46K
Common Stock
Direct
Shares
−2.06K
Price / share
$18.44
Trade value
$38.02K
% of position
27.6%
1/8/2026
7.46K→5.40K
Total
Net shares
+2.94K
Net value
-$38.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/8/2026 | M · Option Exercise | +5K | — | — | 202.9% | 2.46K | 7.46K |
| Common Stock Direct | 1/8/2026 | S · Sale | −2.06K | $18.44 | $38.02K | 27.6% | 7.46K | 5.40K |
| Total | +2.94K | -$38.02K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
5K
Exercisable
—
1/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock5K shares | 1/8/2026 | M · Option Exercise | −5K | — | 5K |